Food News and Research

RSS

GlycosBio, Malaysian Bio-XCell enter agreement to build biochemical plant and biotechnology R&D facility

Glycos Biotechnologies, Inc. (GlycosBio), an emerging biochemical company pioneering metabolic engineering and microbiology innovations for the production of sustainable biochemicals, today exchanged definitive agreements with Malaysian Bio-XCell for the establishment of the Company's industrial biochemical plant and biotechnology R&D facility in Malaysia

1 Nov 2010

Kaplan EduNeering opens new office in Hong Kong

Kaplan EduNeering, a leading provider of compliance and knowledge management solutions, announces today the opening of a Hong Kong office to serve clients based in Asia. The new location, which will house sales and support staff, is based in the Hong Kong offices of its parent company, Kaplan, Inc. In 2008, Kaplan EduNeering opened a European-based location in Reading, England.

1 Nov 2010

FDA grants orphan drug designation to Discovery's KL4 surfactant for CF treatment

Discovery Laboratories, Inc. today announced that the Office of Orphan Products Development of the United States Food and Drug Administration (FDA) has granted orphan drug designation to Discovery's KL4 surfactant for the treatment of cystic fibrosis (CF).

1 Nov 2010

Vascular Pathways closes $14 million Series B equity financing round

Vascular Pathways Inc., a privately held medical device company with a breakthrough product for peripheral intravenous access, today announced that the company has closed a Series B preferred equity financing round of $14 million with premier venture capital firms active in medical technology.

1 Nov 2010

Endo third quarter total revenues increase 23% to $444.1 million

Endo Pharmaceuticals today reported financial results for the third quarter 2010.

1 Nov 2010

Spectrum submits complete response to FDA's CRL for FUSILEV to treat colorectal cancer

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that on Friday, October 29, 2010 it submitted a complete response to the "Complete Response" letter issued by the U.S. Food and Drug Administration (FDA), regarding its supplemental New Drug Application (sNDA) for FUSILEV (levoleucovorin) for Injection for treatment of patients with advanced metastatic colorectal cancer.

1 Nov 2010

FDA grants Clinical Data's PRX-8066 Orphan Drug Designation for pulmonary arterial hypertension

Clinical Data, Inc. today announced that the Office of Orphan Products Development of the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for pulmonary arterial hypertension (PAH) to PRX-8066, the Company's selective serotonin 2B (5-HT2B) receptor antagonist.

1 Nov 2010

Catalina Marketing's blueprint can help shoppers to make positive choices in nutrition, lifestyle management

A new consumer attitude research study conducted by Catalina Marketing, the global leader in shopper-driven marketing solutions, reveals that, despite the industry's healthy-eating consumer initiatives, shoppers have not changed their old buying habits, behavior and perceptions.

1 Nov 2010

Biodel receives FDA CRL for Linjeta NDA

Biodel Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) requesting additional information regarding the company's new drug application (NDA) for Linjeta™ (human insulin [rDNA origin]) injection 100IU/mL for the treatment of type 1 and type 2 diabetes mellitus to improve glycemic control.

1 Nov 2010

America's biopharmaceutical companies researching 98 medicines for Alzheimer's: PhRMA report

As the champagne corks are popping this New Year's Eve, the first American Baby Boomers will turn age 65. Members of the demographic bulge that transformed American politics and culture are expected to usher in yet another momentous change a huge increase in the number of Alzheimer's disease patients.

1 Nov 2010

Consumption of peanut during pregnancy may increase risk of allergy in infants: Study

Researchers have found that allergic infants may be at increased risk of peanut allergy if their mothers ingested peanuts during pregnancy. The data are reported in the November 1, 2010 issue of the Journal of Allergy and Clinical Immunology.

1 Nov 2010

Gilead to present data of two Phase III trials evaluating Viread efficacy for HBV infection at The Liver Meeting 2010

Gilead Sciences, Inc. today announced new data from the open-label phase of two pivotal Phase III clinical trials (Studies 102 and 103) evaluating the four-year efficacy of Viread (tenofovir disoproxil fumarate) for the treatment of chronic hepatitis B virus (HBV) infection.

1 Nov 2010

FDA new approvals, antibiotic and neurological drugs

Two new drugs have gained approval from the US Food and Drug Administration (FDA) – one is an antibiotic from Forest Labs and the other a first-time treatment for a neurological disorder developed by Avanir Pharmaceuticals. Another waiting for approval is Biodel's fast-acting insulin Linjeta. On the other hand seven new drugs got rejected including a diabetes drug from Amylin Pharmaceuticals and weight-loss drugs from Arena Pharmaceuticals and Vivus, respectively.

31 Oct 2010

HDMG and Heritage Health Care host over 4000 seniors at 20th anniversary of Health Expo

Dr. Richard Merkin, High Desert Medical Group and Heritage Health Care hosted over four thousand seniors at their 20th anniversary annual Senior Expo at the Antelope Valley Fairgrounds. Seniors lined up prior to the 9:00 am start, eager to see celebrity Debbie Reynolds perform and get free health screenings and testing including bone density, cholesterol, glucose, blood pressure, body fat, dental and vision screenings and of course, seasonal flu shots.

30 Oct 2010

The Melting Pot joins St. Jude in seventh annual Thanks and Giving campaign

The Melting Pot Restaurants join St. Jude Children's Research Hospital in the seventh annual Thanks and Giving campaign from Nov. 1 - Dec. 4, to give thanks for the healthy kids in your life, and give to those who are not by donating to cancer research.

30 Oct 2010

$700,000 worth of adulterated food seized by U.S. Marshals in Georgia

U.S. Marshals, acting under a court order sought by the U.S. Food and Drug Administration, today seized an estimated $700,000 worth of rice and other packaged food products from a rodent-infested warehouse in East Point, Ga. The FDA-regulated food products were stored in a warehouse operated by Sun Hong Kai Holding Inc., which does business as United Food Service.

30 Oct 2010

Researchers enforce to review current regulation on food advertisements

The researchers, in partnership with the Cancer Council, Australia, studied 12,618 food advertisements from 11 countries and found that 67 per cent endorsed unhealthy food. The research builds on a previous study at Liverpool which revealed that children would consume twice as many calories from snacks after watching food adverts compared to after viewing advertising for toys and games.

30 Oct 2010

Health Canada approves PRADAX for preventing stroke in AF patients

Health Canada, the Canadian health authority, has approved PRADAX™ (dabigatran etexilate), Boehringer Ingelheim's novel, oral direct thrombin inhibitor for the prevention of stroke and systemic embolism in patients with atrial fibrillation (AF) in whom anticoagulation is appropriate, marking the second approval of this new oral anticoagulant following the recent marketing authorisation by the US Food and Drug Administration (FDA).

30 Oct 2010

NOAA and FDA add second chemical test for detecting dispersants in Gulf seafood

Building upon the extensive testing and protocols already in use by federal, state and local officials for the fishing waters of the Gulf, NOAA and FDA have developed and are using a chemical test to detect dispersants used in the Deepwater Horizon-BP oil spill in fish, oysters, crab and shrimp. Trace amounts of the chemicals used in dispersants are common, and levels for safety have been previously set.

30 Oct 2010

ACS to host event on food safety at AAAS auditorium

The American Chemical Society (ACS) invites news media to attend another in a continuing series of discussions with leading scientists, economists, and politicians on a wide range of timely scientific topics, including energy, nuclear terrorism, food safety, and climate and energy policy.

30 Oct 2010

Food News and Research

GlycosBio, Malaysian Bio-XCell enter agreement to build biochemical plant and biotechnology R&D facility

Kaplan EduNeering opens new office in Hong Kong

FDA grants orphan drug designation to Discovery's KL4 surfactant for CF treatment

Vascular Pathways closes $14 million Series B equity financing round

Endo third quarter total revenues increase 23% to $444.1 million

Spectrum submits complete response to FDA's CRL for FUSILEV to treat colorectal cancer

FDA grants Clinical Data's PRX-8066 Orphan Drug Designation for pulmonary arterial hypertension

Catalina Marketing's blueprint can help shoppers to make positive choices in nutrition, lifestyle management

Biodel receives FDA CRL for Linjeta NDA

America's biopharmaceutical companies researching 98 medicines for Alzheimer's: PhRMA report

Consumption of peanut during pregnancy may increase risk of allergy in infants: Study

Gilead to present data of two Phase III trials evaluating Viread efficacy for HBV infection at The Liver Meeting 2010

FDA new approvals, antibiotic and neurological drugs

HDMG and Heritage Health Care host over 4000 seniors at 20th anniversary of Health Expo

The Melting Pot joins St. Jude in seventh annual Thanks and Giving campaign

$700,000 worth of adulterated food seized by U.S. Marshals in Georgia

Researchers enforce to review current regulation on food advertisements

Health Canada approves PRADAX for preventing stroke in AF patients

NOAA and FDA add second chemical test for detecting dispersants in Gulf seafood

ACS to host event on food safety at AAAS auditorium

Understanding cultivated meat and its global potential eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News